title: Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals.
authors.affiliation: Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria, Clemens.Decristoforo@uki.at.
authors.forename: C
authors.initials: C
authors.lastname: Decristoforo
authors.forename: I
authors.initials: I
authors.lastname: Penuelas
authors.forename: P
authors.initials: P
authors.lastname: Elsinga
authors.forename: J
authors.initials: J
authors.lastname: Ballinger
authors.forename: A D
authors.initials: AD
authors.lastname: Winhorst
authors.forename: A
authors.initials: A
authors.lastname: Verbruggen
authors.forename: F
authors.initials: F
authors.lastname: Verzijlbergen
authors.forename: A
authors.initials: A
authors.lastname: Chiti
mesh_terms: D002986:Clinical Trials as Topic; D004339:Drug Compounding; D006801:Humans; D019275:Radiopharmaceuticals; D012926:Social Control, Formal
chemical_list: D019275:Radiopharmaceuticals